Core Viewpoint - Quantum BioPharma Ltd. has purchased an additional USD $5,000,000 worth of Bitcoin and other cryptocurrencies as part of its strategic efforts to enhance shareholder returns and hedge against the dollar [1][2]. Group 1: Cryptocurrency Investment - The total amount of Bitcoin and other cryptocurrencies held by the company now stands at USD $5,000,000 [1]. - The company believes in the potential of cryptocurrencies to provide returns on investment for shareholders [2]. - Quantum BioPharma is set up to receive financing and conduct transactions in cryptocurrencies [2]. Group 2: Compliance and Custodianship - All cryptocurrency holdings are managed by a fully compliant custodian, ensuring adherence to financial and audit regulations [3]. - The company will continue to monitor market conditions and may adjust its cryptocurrency holdings as deemed appropriate [3]. Group 3: Company Overview - Quantum BioPharma is focused on developing innovative biopharmaceutical solutions for neurodegenerative and metabolic disorders [4]. - The company retains a 20.11% ownership stake in Celly Nutrition Corp., which includes a royalty agreement of 7% on sales from its product unbuzzd™ until total payments reach USD $250 million [4]. - Quantum BioPharma maintains a portfolio of strategic investments through its subsidiary, FSD Strategic Investments Inc., which includes loans secured by residential or commercial property [4].
Quantum Biopharma Purchases More Bitcoin (BTC) Bringing the Total Investment in Digital Assets to USD $5,000,000